Azithromycin, levofloxacin up cardiac risk in study of veterans

March 31, 2014
Azithromycin, levofloxacin up cardiac risk in study of veterans

(HealthDay)—Use of azithromycin or levofloxacin is associated with increased risks of death and cardiac arrhythmia compared with amoxicillin use, according to a study published in the March/April issue of the Annals of Family Medicine.

Gowtham A. Rao, M.D., Ph.D., M.P.H., from the University of South Carolina in Columbia, and colleagues conducted a to compare the risk of cardiovascular death and among U.S. veterans taking azithromycin or versus . Participants included veterans (mean age, 56.8 years) who received an exclusive outpatient dispensation for amoxicillin (979,380 ), azithromycin (594,792 patients), or levofloxacin (201,798 patients) between September 1999 and April 2012. Azithromycin was mainly dispensed for five days, while amoxicillin and levofloxacin were usually dispensed for 10 days or longer.

The researchers found that, compared with patients receiving amoxicillin, the risks of death and serious arrhythmia were significantly increased for patients receiving azithromycin (hazard ratios, 1.48 and 1.77, respectively) during days one to five, but the risks were not significantly different on treatment days six to 10. An increased risk of death and serious cardiac arrhythmia was seen for patients receiving levofloxacin versus amoxicillin for days one to five (hazard ratios, 2.49 and 2.43, respectively). For both death and arrhythmia, the risks remained significantly elevated for days six to 10 (hazard ratios, 1.95 and 1.75, respectively).

"There are usually multiple antibiotic choices available for older patients, especially those with cardiac comorbidities; physicians may consider prescribing medications other than azithromycin and levofloxacin," the authors write.

Explore further: Study finds common antibiotic azithromycin carries heart risk

More information: Abstract
Full Text

Related Stories

Study finds common antibiotic azithromycin carries heart risk

May 16, 2012
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...

Azithromycin not tied to increased risk of CV death

May 2, 2013
(HealthDay)—The widely used antibiotic azithromycin (Zithromax or Zmax)—under scrutiny recently because it may increase the risk of death for those with existing heart disease—appears to be safe for young and middle-aged ...

Study examines risk of severe blood sugar swings among diabetics taking fluoroquinolones

August 15, 2013
Diabetic patients taking oral fluoroquinolones, a frequently prescribed class of antibiotics, were found to have a higher risk of severe blood sugar-related problems than diabetic patients taking other kinds of antibiotics, ...

Nocturnal respiratory rate predicts cardiac risk after MI

March 10, 2014
(HealthDay)—Among survivors of acute myocardial infarction (MI), nocturnal respiratory rate (NRR) is significantly associated with cardiac mortality, particularly non-sudden cardiac death, according to research published ...

Azithromycin may provide benefit for treatment of respiratory disorder

March 26, 2013
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a ...

Common antibiotics pose a rare risk of severe liver injury in older patients

August 13, 2012
The commonly used broad-spectrum antibiotics moxifloxacin and levofloxacin are associated with an increased risk of severe liver injury in older people, according to a new study published in CMAJ (Canadian Medical Association ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.